Anti cancer therapy breast anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Neoplastic Stem Cells HCT116 Cells Cell Line HT29 Cells HeLa Cells

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases43

Neoplasms Radiation Injuries Carcinoma, Ductal, Breast Breast Diseases Breast Neoplasms Neoplasm Metastasis Lung Neoplasms Colonic Neoplasms Ovarian Neoplasms Neoplasm Invasiveness Prostatic Neoplasms Neoplasms, Radiation-Induced Carcinoma Breast Neoplasms, Male Pancreatic Neoplasms Stomach Neoplasms Neovascularization, Pathologic Adenocarcinoma Cell Transformation, Neoplastic Disease Progression Neoplasm Recurrence, Local Radiation Injuries, Experimental Carcinoma, Squamous Cell Radiation Pneumonitis Mammary Neoplasms, Experimental Neoplasms, Experimental Fibrocystic Breast Disease Carcinoma, Non-Small-Cell Lung Genetic Predisposition to Disease Uterine Cervical Neoplasms Colorectal Neoplasms Carcinoma, Intraductal, Noninfiltrating Head and Neck Neoplasms Brain Neoplasms Carcinoma, Lobular Liver Neoplasms Neoplasms, Hormone-Dependent Bone Neoplasms Urinary Bladder Neoplasms Neoplasms, Second Primary Melanoma Disease Models, Animal Skin Neoplasms

Chemicals and Drugs71

Antineoplastic Agents Antineoplastic Agents, Phytogenic Cisplatin Neoplasm Proteins Doxorubicin Antibiotics, Antineoplastic Receptors, Estrogen Receptor, erbB-2 Tumor Markers, Biological Tumor Suppressor Protein p53 Drug Carriers Tamoxifen RNA, Small Interfering RNA, Messenger Fluorouracil Antibodies, Monoclonal Radiation-Sensitizing Agents Paclitaxel Receptors, Progesterone Enzyme Inhibitors Camptothecin DNA, Neoplasm Antineoplastic Agents, Hormonal Cancer Vaccines Etoposide Plant Extracts P-Glycoprotein Antimetabolites, Antineoplastic Anticarcinogenic Agents Proto-Oncogene Proteins c-bcl-2 DNA Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Antigens, Neoplasm DNA-Binding Proteins Tumor Suppressor Proteins Taxoids Ellipticines Caspases Protein-Serine-Threonine Kinases Caspase 3 Proto-Oncogene Proteins c-akt Antibodies, Monoclonal, Humanized Deoxycytidine Prodrugs Organoplatinum Compounds DNA Adducts Estrogens Estrogen Receptor alpha Antineoplastic Agents, Alkylating Apoptosis Regulatory Proteins Nuclear Proteins Proto-Oncogene Proteins Nanocapsules Cyclophosphamide Histone Deacetylase Inhibitors Platinum RNA, Neoplasm Topoisomerase I Inhibitors Radiation-Protective Agents Vinblastine DNA Topoisomerases, Type II Cell Cycle Proteins Quinazolines BRCA1 Protein Transcription Factors MicroRNAs BRCA2 Protein Poly(ADP-ribose) Polymerases Daunorubicin Angiogenesis Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Radiation Dosage Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Xenograft Model Antitumor Assays Drug Delivery Systems Radiation Monitoring Radiotherapy Molecular Targeted Therapy Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Early Detection of Cancer Prognosis Combined Modality Therapy Blotting, Western Mammography Drug Carriers Reverse Transcriptase Polymerase Chain Reaction Transplantation, Heterologous Neoplasm Staging Clinical Trials as Topic Survival Analysis Tumor Burden Gene Expression Profiling Models, Biological Treatment Outcome Survival Rate Radiotherapy Dosage Retrospective Studies Chemotherapy, Adjuvant Follow-Up Studies Immunohistochemistry Inhibitory Concentration 50 Drug Design Risk Factors Radiation Injuries, Experimental Transfection Mammary Neoplasms, Experimental Mastectomy Disease-Free Survival Neoplasms, Experimental Prospective Studies Radiometry Flow Cytometry Risk Risk Assessment Breast Self-Examination Sensitivity and Specificity Radiotherapy, Adjuvant Breast Implants Oligonucleotide Array Sequence Analysis Genetic Therapy Drug Evaluation, Preclinical Reproducibility of Results Models, Molecular Gene Knockdown Techniques Drug Discovery Registries Mastectomy, Segmental Immunotherapy Polymerase Chain Reaction Tumor Stem Cell Assay Odds Ratio Nanocapsules Hyperthermia, Induced Multivariate Analysis Immunoenzyme Techniques SEER Program Kaplan-Meier Estimate Phytotherapy Incidence Drug Administration Schedule Disease Models, Animal Ultrasonography, Mammary Magnetic Resonance Spectroscopy

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes55

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Apoptosis Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Radiation Cell Survival Cell Proliferation DNA Damage Breast Feeding Cell Cycle Signal Transduction Dose-Response Relationship, Drug Gamma Rays Time Factors Cell Division Drug Synergism Mutation Molecular Structure Cosmic Radiation Inhibitory Concentration 50 Down-Regulation Transfection Drug Resistance, Multiple DNA Repair Cell Growth Processes Genetic Predisposition to Disease Base Sequence RNA Interference Risk Ultraviolet Rays Genes, BRCA1 Sensitivity and Specificity Phosphorylation Cell Movement Up-Regulation Background Radiation Cell Death Gene Expression Promoter Regions, Genetic Gene Silencing Genes, p53 Postmenopause DNA Methylation DNA Adducts Odds Ratio Radiation Effects Structure-Activity Relationship Enzyme Activation Tumor Microenvironment Protein Binding Phenotype Genes, BRCA2

Disciplines and Occupations6

Radiation Oncology Immunohistochemistry Drug Design Nanomedicine Medical Oncology Drug Discovery

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Information Science6

Survival Rate Molecular Sequence Data Base Sequence Registries SEER Program Incidence

Named Groups1

Health Care30

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Clinical Trials as Topic Survival Analysis Treatment Outcome Cosmic Radiation Survival Rate Retrospective Studies Follow-Up Studies Risk Factors Radiation Injuries, Experimental Disease-Free Survival National Cancer Institute (U.S.)Prospective Studies Risk Risk Assessment Ultraviolet Rays Sensitivity and Specificity Age Factors Reproducibility of Results Registries Odds Ratio Radiation Effects Multivariate Analysis SEER Program Kaplan-Meier Estimate Incidence

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Breast Antineoplastic Agents Neoplasms Cell Line, Tumor Radiation Dosage Radiation, Ionizing Radiation Injuries Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Radiation Tolerance Carcinoma, Ductal, Breast Apoptosis Drug Resistance, Neoplasm Breast Diseases Mice, Nude Gene Expression Regulation, Neoplastic Radiation Xenograft Model Antitumor Assays Tumor Cells, Cultured Cell Survival Cell Proliferation Radiation Protection Drug Delivery Systems Breast Neoplasms Antineoplastic Agents, Phytogenic Radiation Monitoring Neoplasm Metastasis Cisplatin Neoplasm Proteins Lung Neoplasms Colonic Neoplasms Ovarian Neoplasms Doxorubicin Antibiotics, Antineoplastic Neoplasm Invasiveness Receptors, Estrogen Prostatic Neoplasms Receptor, erbB-2 Radiotherapy Molecular Targeted Therapy DNA Damage Antineoplastic Combined Chemotherapy Protocols Radiation Oncology Breast Feeding Neoplasm Transplantation Early Detection of Cancer Prognosis Tumor Markers, Biological Tumor Suppressor Protein p53 Cell Cycle Signal Transduction Dose-Response Relationship, Drug Combined Modality Therapy Neoplasms, Radiation-Induced Blotting, Western Mammography Carcinoma Drug Carriers Tamoxifen RNA, Small Interfering MCF-7 Cells Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger Breast Neoplasms, Male Fluorouracil Antibodies, Monoclonal Gamma Rays Transplantation, Heterologous Time Factors Neoplasm Staging Radiation-Sensitizing Agents Clinical Trials as Topic Paclitaxel Cell Division Survival Analysis Drug Synergism Pancreatic Neoplasms Mutation Tumor Burden Receptors, Progesterone Gene Expression Profiling Stomach Neoplasms Models, Biological Molecular Structure Treatment Outcome Cosmic Radiation Enzyme Inhibitors Survival Rate Radiotherapy Dosage Camptothecin Retrospective Studies Nanoparticles DNA, Neoplasm Chemotherapy, Adjuvant Follow-Up Studies Immunohistochemistry Inhibitory Concentration 50 Drug Design Neovascularization, Pathologic Adenocarcinoma

No FAQ available that match "anti cancer therapy breast anticancer drugs or radiation"